Details of the Drug Formulaction

General Information of Drug Formulation (ID: F24093)

• Formulation Name: Nifurtimox 30 mg tablet
• Company: Bayer Healthcare Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Nifurtimox	(DMSQLZJ)	Chagas disease	IF53	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Brushite	(E00392)	104805	Diluent
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Magnesium stearate	(E00208)	11177	lubricant
Pregelatinized starch	(E00674)	Not Available	Binding agent; Diluent; Disintegrant
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant